127 related articles for article (PubMed ID: 6417867)
1. Effects of continuous levonorgestrel treatment (subcutaneous capsules) on the lipoprotein and carbohydrate metabolism in fertile women.
Lithell H; Weiner E; Vessby B; Johansson ED
Ups J Med Sci; 1983; 88(2):103-8. PubMed ID: 6417867
[TBL] [Abstract][Full Text] [Related]
2. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipoproteins and fatty acid composition after "minipill".
Sassolas A; Lagarde M; Guichardant M; Quincy C; Dechavanne M
Contraception; 1983 Oct; 28(4):357-68. PubMed ID: 6421540
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
Loke DF; Ng CS; Samsioe G; Holck S; Ratnam SS
Contraception; 1990 Nov; 42(5):535-54. PubMed ID: 2125546
[TBL] [Abstract][Full Text] [Related]
5. Effects of desogestrel and levonorgestrel in low-dose oestrogen oral contraceptives on serum lipoproteins.
Bergink EW; Borglin NE; Klottrup P; Liukko P
Contraception; 1982 May; 25(5):477-85. PubMed ID: 6213374
[No Abstract] [Full Text] [Related]
6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
7. Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins.
Bergink EW; Kloosterboer HJ; Lund L; Nummi S
Contraception; 1984 Jul; 30(1):61-72. PubMed ID: 6236951
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins.
Ahrén T; Lithell H; Victor A; Vessby B; Johansson ED
Contraception; 1981 Oct; 24(4):451-68. PubMed ID: 6797786
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipids and lipoprotein lipase activating property in women on three different combinations of estrogens and progestins.
Mendoza SG; Kashyap ML; Echeverria Y; Zerpa A
Biochem Med; 1981 Jun; 25(3):283-7. PubMed ID: 7271764
[TBL] [Abstract][Full Text] [Related]
11. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
12. Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses.
Krauss RM; Roy S; Mishell DR; Casagrande J; Pike MC
Am J Obstet Gynecol; 1983 Feb; 145(4):446-52. PubMed ID: 6401927
[TBL] [Abstract][Full Text] [Related]
13. Effects of oestradiol and levonorgestrel on lipoprotein lipids and postheparin plasma lipase activities in normolipoproteinaemic women.
Tikkanen MJ; Nikkilä EA; Kuusi T; Sipinen S
Acta Endocrinol (Copenh); 1982 Apr; 99(4):630-5. PubMed ID: 6803493
[TBL] [Abstract][Full Text] [Related]
14. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers.
Samsioe G
Contraception; 1982 May; 25(5):487-503. PubMed ID: 6213375
[No Abstract] [Full Text] [Related]
16. Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens.
Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
Maturitas; 1982 Aug; 4(2):103-11. PubMed ID: 6811837
[TBL] [Abstract][Full Text] [Related]
17. Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD.
Croxatto HB; Diaz S; Robertson DN; Pavez M
Contraception; 1983 Mar; 27(3):281-8. PubMed ID: 6406139
[TBL] [Abstract][Full Text] [Related]
18. Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
Roy S; Mishell DR; Robertson DN; Krauss RM; Lacarra M; Duda MJ
Am J Obstet Gynecol; 1984 Apr; 148(7):1006-13. PubMed ID: 6424474
[TBL] [Abstract][Full Text] [Related]
19. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
Larsson-Cohn U; Wallentin L; Zador G
Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]